Device typeTotal prostate specific antigen (tPSA) IVD, kit, chemiluminescent immunoassay: A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of total prostate specific antigen (tPSA) in a clinical specimen, using a chemiluminescent immunoassay method.
FDA categoryPROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS
Device ID00816870022291
Catalog number2175-300A
AvailabilityPrescription
MRI safetyLabeling does not contain MRI Safety Information
Width7.75 Inch